Refreshing results…
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
UploadA First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer
Download from aacrjournals.orgProteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells
Download from www.nature.comFoxM1 insufficiency hyperactivates Ect2–RhoA–mDia1 signaling to drive cancer
Download from www.nature.comA selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
UploadMissing publications? Search for publications with a matching author name.